LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-300
| Closed | -$2.26K | – | 654 |
|
|
2023
Q2 | $2.26K | Hold |
300
| – | – | ﹤0.01% | 609 |
|
|
2023
Q1 | $2.66K | Buy |
+300
| New | +$2.66K | ﹤0.01% | 564 |
|
|
2019
Q1 | – | Sell |
-300
| Closed | -$5K | – | 758 |
|
|
2018
Q4 | $5K | Hold |
300
| – | – | ﹤0.01% | 602 |
|
|
2018
Q3 | $6K | Sell |
300
-300
| -50% | -$6K | ﹤0.01% | 561 |
|
|
2018
Q2 | $15K | Hold |
600
| – | – | ﹤0.01% | 526 |
|
|
2018
Q1 | $10K | Hold |
600
| – | – | ﹤0.01% | 583 |
|
|
2017
Q4 | $11K | Sell |
600
-510
| -46% | -$9.35K | ﹤0.01% | 565 |
|
|
2017
Q3 | $20K | Buy |
1,110
+390
| +54% | +$7.03K | ﹤0.01% | 509 |
|
|
2017
Q2 | $23K | Sell |
720
-130
| -15% | -$4.15K | ﹤0.01% | 482 |
|
|
2017
Q1 | $27K | Hold |
850
| – | – | ﹤0.01% | 471 |
|
|
2016
Q4 | $31K | Hold |
850
| – | – | ﹤0.01% | 438 |
|
|
2016
Q3 | $39K | Hold |
850
| – | – | ﹤0.01% | 420 |
|
|
2016
Q2 | $43K | Sell |
850
-550
| -39% | -$27.8K | ﹤0.01% | 409 |
|
|
2016
Q1 | $75K | Hold |
1,400
| – | – | ﹤0.01% | 341 |
|
|
2015
Q4 | $92K | Buy |
1,400
+550
| +65% | +$36.1K | ﹤0.01% | 348 |
|
|
2015
Q3 | $50K | Hold |
850
| – | – | ﹤0.01% | 417 |
|
|
2015
Q2 | $50K | Hold |
850
| – | – | ﹤0.01% | 417 |
|
|
2015
Q1 | $53K | Hold |
850
| – | – | ﹤0.01% | 426 |
|
|
2014
Q4 | $49K | Hold |
850
| – | – | ﹤0.01% | 428 |
|
|
2014
Q3 | $46K | Sell |
850
-1,000
| -54% | -$54.1K | ﹤0.01% | 423 |
|
|
2014
Q2 | $97K | Sell |
1,850
-8,215
| -82% | -$431K | ﹤0.01% | 361 |
|
|
2014
Q1 | $532K | Buy |
10,065
+250
| +3% | +$13.2K | 0.01% | 186 |
|
|
2013
Q4 | $393K | Hold |
9,815
| – | – | 0.01% | 204 |
|
|
2013
Q3 | $371K | Sell |
9,815
-1,435
| -13% | -$54.2K | 0.01% | 201 |
|
|
2013
Q2 | $441K | Buy |
+11,250
| New | +$441K | 0.01% | 200 |
|